MoonLake Immunotherapeutics Files Biologics License Application To FDA For Nanobody Sonelokimab To Treat Hidradenitis Suppurativa

Benzinga Newsdesk www.benzinga.com Neutral 92.2%

Neg 0% Neu 92.2% Pos 0%

https://www.sec.gov/ix?doc=/Archives/edgar/data/1821586/000121390026105240/ea0307097-8k_moonlake.htm

Comments

No comments yet. Be the first!